---
title: "诺和诺德股价下跌 2.3%，在其收购美特拉的出价公布后跌幅扩大。"
description: "诺和诺德股价下跌 2.3%，在其收购美特拉的出价公布后跌幅扩大。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263484695.md"
published_at: "2025-10-30T10:20:47.000Z"
---

# 诺和诺德股价下跌 2.3%，在其收购美特拉的出价公布后跌幅扩大。

诺和诺德股价下跌 2.3%，在其收购美特拉的出价公布后跌幅扩大。

### Related Stocks

- [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GLP-1 Anti-Obesity U.S. Drug Market In Four Charts | UBS analysts, led by Matthew Weston, have analyzed trends in the U.S. GLP-1 anti-obesity drug market, focusing on new-to | [Link](https://longbridge.com/zh-CN/news/276280378.md) |
| Novo Nordisk A/S - share repurchase programme | Novo Nordisk A/S has initiated a share repurchase programme of up to DKK 15 billion, starting from 4 February 2026. As o | [Link](https://longbridge.com/zh-CN/news/276056741.md) |
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/zh-CN/news/275652909.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/zh-CN/news/275789396.md) |
| Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU) | Berenberg Bank analyst Kerry Holford has reaffirmed a Buy rating on Novo Nordisk (0QIU) with a price target of DKK360.00 | [Link](https://longbridge.com/zh-CN/news/275719942.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。